In the CodeBreaK 300 trial, sotorasib and panitumumab had better response rates and improved PFS vs standard-of-care ...

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and ...

Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...

Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab) combination has received approval from the US Food and Drug ...

The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.

Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.

WASHINGTON — President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President ...

The broader Topix index settled 1.19 percent higher at 2,711.27. Automakers led the surge, with Honda Motor rising 1.4 percent while Toyota Motor and Subaru both gained around 3 percent.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

President-elect Trump campaigned on leaving abortion decisions to the states, but that could prove a tough promise to keep as ...